{"name":"Progen Pharmaceuticals","slug":"progen-pharmaceuticals","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"CGC-11047 and docetaxel","genericName":"CGC-11047 and docetaxel","slug":"cgc-11047-and-docetaxel","indication":"Other","status":"phase_1"},{"name":"CGC-11047 and erlotinib","genericName":"CGC-11047 and erlotinib","slug":"cgc-11047-and-erlotinib","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"CGC-11047 and docetaxel","genericName":"CGC-11047 and docetaxel","slug":"cgc-11047-and-docetaxel","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"CGC-11047 and erlotinib","genericName":"CGC-11047 and erlotinib","slug":"cgc-11047-and-erlotinib","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-01-08","type":"regulatory","source":"Business Wire","summary":"GLP-1 Market Trends and Global Forecasts 2025-2035: 150+ Candidates Intended for the Treatment of Multiple Indications, are Currently Either Approved or Being Investigated - ResearchAndMarkets.com - B","headline":"GLP-1 Market Trends and Global Forecasts 2025-2035: 150+ Candidates Intended for the Treatment of Multiple Indications, ","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE9FM0taRmZZSzFRNjVVcWtUajZLMnJJMXlmaUFpU2ZZMGtKSUpBSXhYZ0plc2E3UUt3VzNRYmdwcUdoWl9ickFLcDhNZWRyclFLMDR3?oc=5","date":"2025-12-24","type":"pipeline","source":"Wowtale","summary":"Dasan Pharma. Raises $8.8M Pre-IPO to Expand Production and Accelerate Global CDMO Market Entry - Wowtale","headline":"Dasan Pharma. Raises $8.8M Pre-IPO to Expand Production and Accelerate Global CDMO Market Entry","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgJBVV95cUxNRXEzdmhiYk10Z0NvVkt6T3BTcXpqaGEtX2NyYnlVVGUwbWp3SVlYdVBRQ215SjNsMktwajRqLUkzQXl2Mm5wcV90SkJpTlF0OURlSWg4UEZqNEcxelYtNFhrbkFWRTBTX0ZVejctNUdIbjhFTmpDVFNvNUo2TVFvcW9JVGdmZV9VOFQ5MmtNV2ZCdGMtbWp2ekFaVlI3Mlk1Z21DSjVEdmhESXlKUG5nSDQtVlg3U1hsaUhRb19aLTZ4aFZLd0QwaE1aNm9wRmtxalNPZ0ktdEFYWGI3VDdkc0pBQm5WOXBKZ0E2aVNyVEtPZTc5OUZadFNiUE92bW45Rm1fcTZLX3FnRHZzcVE?oc=5","date":"2025-10-27","type":"pipeline","source":"PR Newswire","summary":"Designs for Health Launches Progenalen® Pro Peptide Breakthrough Triple Action Solution for Metabolic Health and Healthy Aging - PR Newswire","headline":"Designs for Health Launches Progenalen® Pro Peptide Breakthrough Triple Action Solution for Metabolic Health and Healthy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5Yc0lpa1Vnb000bTQyTnZHNGYzTkJBRXhRbTJmVEJDT0ZXUk14WEFnYVFFUDZtMjVPTS1Jc2NEZG5NbDZ2UHA4OE0tVHMxM29BVXF6OFplZHpWWmZaYXZwWlZjbnZQSDRJY010dzh30gFyQVVfeXFMTW5sOVB5ZjFzd09XVmFuaURWUVQ0OS1uNC1xdzJCalZxUVl0VWt6d3o1VjFpdzgybU1VQUk2SHVNZzkzU0liNnYtdlpfd3pCcnR2RzVkZWtHRkdmWWVkaVNxaHYyRnFyNzdNUDFQQmY2amx3?oc=5","date":"2025-09-19","type":"trial","source":"koreabiomed.com","summary":"ProGen releases PG-102 clinical trial results at European diabetes meeting - koreabiomed.com","headline":"ProGen releases PG-102 clinical trial results at European diabetes meeting","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1xUkZQc1BlTjhtYkJ4VUc3dUFzTE5PZWNPWVBlalU4bUtYMGU5QXBGb3o3TXEwMk9NWkRlS0VpT2xJUlk5RE1WRDZlbGpZZ0ZNa3o0bEVLZlBrZUh0V3NwaGs1U1k4RGp4RjN1VTRB0gFyQVVfeXFMTWE4YzhTTlVRWmtteVpnSVU2TF93dnVMMEt3MktJLUNGenJrS1NBQV9QRkFyRDQzOU9OVFJFVWVHd3NYcjlZTEtReUwwSGNiLWtlTmRULV9NWHZMVmgtc09NMnAtWHpxeS04cnJKQm0wcFJB?oc=5","date":"2025-08-13","type":"regulatory","source":"koreabiomed.com","summary":"Daewoong’s semaglutide microneedle patch hits 80% absorption, challenges injection dominance - koreabiomed.com","headline":"Daewoong’s semaglutide microneedle patch hits 80% absorption, challenges injection dominance","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBpVW52emlrWTRBUlY0OV9wejhhNmx1VDZCYmEybmtadGQ4UVFCZlN5ejFIbTJfNXFiTXJ6WVh1VmlONWI4a3p6anV0YjlscVl3cWd5czNQNlU5QTh5S2JjYmxJR1hnNDFObmN4Qi1n0gFyQVVfeXFMTkdyRWUzQWVtZzlxdEhVanV3dFFJV0ZxdGZHRm5NSDlvSVp0bWdpOUhvMENUbnZuWFlLOUdubzJHRDZMOXF3OERJN1ZNc1dMVWM0RFBFUHlocW43QkZlbXhBNXNwMHJSZ1ZwTjFBenhMMHJ3?oc=5","date":"2025-07-11","type":"pipeline","source":"koreabiomed.com","summary":"Yuhan expands obesity pipeline with next-gen drugs, reformulated therapies - koreabiomed.com","headline":"Yuhan expands obesity pipeline with next-gen drugs, reformulated therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9yNzFzcUozOUpOSk5QcXF1T3Q1VVk3TjlUQXp0T04xUTRPUW52cERhbVlyN3BMZW1yMjZGeTdKOHFjLW1HQlNlaTlQX18zXzJwNzdJa1prc2VKNHFiYUkzUXhtNGd3YUFuV2l0Z2hR0gFyQVVfeXFMTVZ4WGNHNHQ0aGpSbFV4cmxQaGhkZGQ5d0VjdHNsVl9HV3JpczVMMEJMWDFBRFFKeU5wckhEM3puRmNPTGF4R0RwRlJpMFk3ZG0tX3V5aUR4ZGlGNkJUUkc1V1hGTm1jaUw2NXVvWFBHU293?oc=5","date":"2025-04-18","type":"pipeline","source":"koreabiomed.com","summary":"ProGen lands $15.5 mil. from Yuhan, new backer JW to advance dual-target obesity drug - koreabiomed.com","headline":"ProGen lands $15.5 mil. from Yuhan, new backer JW to advance dual-target obesity drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTFBYOXZmWVM0MzdTNnZYN3NSbjhuenRaSV9IclVxZTNlWUJDb2EzRDVveXk4R05OODZxbm5RNkFmQjlDVHdEMzkzQlBBR2JHWjlydURHUDhqQmhJZWEyVUkza1VlMW9Zc2pUUV9zVE00RQ?oc=5","date":"2025-02-13","type":"pipeline","source":"medwatch.com","summary":"Advised by former Novo Nordisk boss: Biotech company turns weight-loss drug into robotic tablet - medwatch.com","headline":"Advised by former Novo Nordisk boss: Biotech company turns weight-loss drug into robotic tablet","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiQkFVX3lxTE1PaE9TV2R5Uk1mOVo4S1h6VWpWY2U3dmFsVEd5V3NFajV6VXJidU5mUGhzdi1kLVhwUzl0M2tfWXI1QQ?oc=5","date":"2024-07-11","type":"pipeline","source":"코메디닷컴","summary":"D&D Pharmatech \"Confident in MASH and Obesity Drug Efficacy…Targeting 100 Trillion Won Market\" - 코메디닷컴","headline":"D&D Pharmatech \"Confident in MASH and Obesity Drug Efficacy…Targeting 100 Trillion Won Market\" - 코메디닷컴","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFB4a0FVNzhFdy13ZUdIZVVQYTZsMk5RM2FyVXFxYUpUOHJEYTFmY19KUDRWQWVyVFI1S1lCSWFDY3ladjByMDJGakFGSGdPMGF2ZnVxTVFzSGRCRkhXLXNDcEc4bkNidWJnM2FZTjFn0gFyQVVfeXFMTzNIU0pPNEtpak5QS3o5b2ZqMVJjbDRlQWhWaVBaWFlCRHBNb2l4S1ExLWttVnJHcHFsLWFJTFhQUWE2bzRsSUE4eEZOWUNOTVBQNW5rRkpoYURXQUtKOGJySUNoQ1lQT1oycmIxTkxTVjh3?oc=5","date":"2024-06-25","type":"pipeline","source":"koreabiomed.com","summary":"ProGen, Rani Therapeutics collaborate to develop weekly obesity capsule - koreabiomed.com","headline":"ProGen, Rani Therapeutics collaborate to develop weekly obesity capsule","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxQaXJETlBqUWszdEhMMEhSeThHNnRsVVVCOS1jS1hlam1HdW9oQkVhcXptQVhsQkdVcGlOTGxoTjBvS0NPZ3kyVDdxamg4QlRjeVFkczF3WXNWY2dxUFhoRHV3Ti1ReGRwVmRCSHR4RlNhaE5FV3IwdU1OVjBZTEFmY0VmZ2lMMGF4YjgwelZjVEM0REJIV1VReWt3b3RpUkpWdTVHMWg5VHNTcXpSQTZQU2o2d2pHLTA?oc=5","date":"2024-06-24","type":"deal","source":"Contract Pharma","summary":"Rani, ProGen Partner to Co-Develop & Commercialize Oral Obesity Treatment - Contract Pharma","headline":"Rani, ProGen Partner to Co-Develop & Commercialize Oral Obesity Treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQT2JMcHd5MFpLWVRQczFadWZUQ3dwSzljWW55YXNXcHhnVUNFeW1RLUZ1MEhvWEFSM3hKR2pkTG4tang2WDlEUWtpZnY4T1JMN2c1NmlzdmpXYzVFMldPWWpyUzh6MTU3LWRzQnFRYndHdExHRjRKV2NXMktxSVF2end1Q3Q4V1RxM1ROVm1obkg5UkxmYjR4VmljeTVkS0k?oc=5","date":"2024-05-08","type":"pipeline","source":"BioWorld News","summary":"Bio Korea 2024: What’s next after GLP-1 in obesity, diabetes? - BioWorld News","headline":"Bio Korea 2024: What’s next after GLP-1 in obesity, diabetes?","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_1":2},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}